Acasă › Cancer pulmonar › Illinois › Evanston
Studii clinice pentru Cancer pulmonar în Evanston, IL
19 studii pentru Cancer pulmonar caută participanți în și în jurul orașului Evanston (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
În curs de recrutareFaza 3
- NorthShore University HealthSystem-Evanston Hospital, Evanston
- NorthShore University HealthSystem-Glenbrook Hospital, Glenview · La 5 mi distanță
- Advocate Lutheran General Hospital, Park Ridge · La 8 mi distanță
- și încă 1
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- Advocate Lutheran General Hospital, Park Ridge · La 8 mi distanță
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
În curs de recrutareFaza 3
- Advocate Lutheran General Hospital, Park Ridge · La 8 mi distanță
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
În curs de recrutareFaza 3
- Northwestern Medicine Glenview Outpatient Center, Glenview · La 5 mi distanță
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
În curs de recrutareFaza 3
- Northwestern Medicine Glenview Outpatient Center, Glenview · La 5 mi distanță
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
În curs de recrutareFaza 3
- North Shore University Health System ( Site 4014), Evanston
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
În curs de recrutareFaza 3
- Illinois Cancer Specialists, Niles · La 6 mi distanță
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
În curs de recrutareFaza 3
- Illinois Cancer Specialists, Niles · La 6 mi distanță
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
În curs de recrutareFaza 3
- Advocate Lutheran General Hospital, Park Ridge · La 8 mi distanță
A Registry for People With Lung Cancer
În curs de recrutareStudiu observațional
- Endeavor Health, Evanston
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
În curs de recrutareFaza 3
- Illinois Cancer Specialists, Niles · La 6 mi distanță
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
În curs de recrutareFaza 3
- Advocate Lutheran General Hospital, Park Ridge · La 8 mi distanță
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
În curs de recrutareFaza 2
- Advocate Aurora Health, Park Ridge · La 8 mi distanță
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · La 5 mi distanță
- Advocate Lutheran General Hospital, Park Ridge · La 8 mi distanță
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · La 5 mi distanță
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2/3
- Northwestern Medicine Glenview Outpatient Center, Glenview · La 5 mi distanță
- Advocate Lutheran General Hospital, Park Ridge · La 8 mi distanță
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
În curs de recrutareVoluntari sănătoși bineveniți
- Northwestern University, Evanston
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
În curs de recrutareStudiu observațional
- Northshore University Health System, Evanston
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
În curs de recrutareStudiu observațional
- Advocate Lutheran General Hospital, Park Ridge · La 8 mi distanță
Studii pentru Cancer pulmonar în alte orașe
- Houston, TX78 studii
- Boston, MA62 studii
- New York City, NY60 studii
- Los Angeles, CA45 studii
- Washington, DC41 studii
- Arlington, VA41 studii
- Chicago, IL41 studii
- Nashville, TN40 studii
- Baltimore, MD40 studii
- St. Louis, MO39 studii
- Columbus, OH37 studii
- Philadelphia, PA36 studii
Alte studii în Evanston
- Cancer pulmonar cu celule non-pătrate22 studii
- Cancer de sân13 studii
- Leucemie mieloasă acută11 studii
- Obezitate11 studii
- Cancer colorectal10 studii
- Cancer (toate tipurile)9 studii
- Supraponderalitate9 studii
- Colită ulcerativă9 studii
- Cancer de prostată9 studii
- Boala Crohn9 studii
- Insuficiență cardiacă8 studii
- Fibrilație atrială8 studii
Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.